Synthetic Analogs of Streptococcus pneumoniae Capsular Polysaccharides and Immunogenic Activities of Glycoconjugates

M L Gening1, E A Kurbatova2, N E Nifantiev1

  • 1Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.

Insights

Synthetic oligosaccharides offer a promising approach to overcome the low immunogenicity of certain pneumococcal serotypes. These novel constructs can induce protective antibodies and immunological memory, aiding in the development of advanced pneumococcal vaccines and diagnostics.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Streptococcus pneumoniae (pneumococcus) causes severe diseases globally.
  • Current pneumococcal vaccines have limitations due to low immunogenicity of some capsular polysaccharides.

Purpose of the Study:

  • To review production methods and structural features of synthetic oligosaccharides for problematic pneumococcal serotypes.
  • To explore the potential of synthetic oligosaccharides in developing new pneumococcal vaccines and diagnostic tools.

Main Methods:

  • Analysis of production methods for synthetic oligosaccharides.
  • Evaluation of structural features influencing immunogenicity.
  • Review of studies demonstrating antibody and memory induction by synthetic glycotopes.

Main Results:

  • Synthetic oligosaccharides can overcome low immunogenicity issues associated with certain pneumococcal serotypes.
  • These synthetic constructs induce protective opsonizing antibodies and immunological memory.
  • Optimal oligosaccharide constructs are identified for vaccine design and diagnostic systems.

Conclusions:

  • Synthetic oligosaccharides are a viable strategy for next-generation pneumococcal vaccines.
  • These molecules can be utilized for improved diagnostics and monitoring of pneumococcal infections and vaccination efficacy.

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
23.3K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.2K
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
1.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
896